Precautions in the instructions for Apelix

1. Indications

Alpelisib (Alpelisib) is a PI3Kα inhibitor, mainly used to treat HR-positive, HER2-negative, PIK3CA gene-mutated advanced or metastatic breast cancer. It is usually used in combination with fulvestrant (Fulvestrant) and is suitable for postmenopausal women or men whose disease has progressed despite previous endocrine therapy. The drug inhibits the proliferation and spread of cancer cells by targeting the growth of tumor cells caused by PIK3CA mutations.

2. Usage and Dosage

The recommended dose of Apelvis is 300mg once a day (i.e. 150mg*2 tablets), taken with food. If serious adverse reactions occur, the doctor may adjust the dose, such as reducing it to 250mg or 200mg once a day, or suspend the medication if necessary. When taking the medicine, swallow the tablet whole and avoid chewing, breaking or grinding to ensure stable release and optimal absorption of the medicine.

3. Precautions for use

Dietary requirements: Apelix must be taken with meals, otherwise the efficacy of the drug may be affected. Avoid foods high in sugar and fat to reduce the risk of side effects such as high blood sugar.

Blood sugar monitoring: This drug may cause hyperglycemia. It is recommended to regularly monitor fasting blood sugar and glycated hemoglobin (HbA1c). Diabetic patients need to pay special attention to blood sugar control.

Adverse skin reactions: Apelvis may cause rash, erythema, or severe skin reactions. If symptoms worsen, you should inform your doctor in time.

Other common side effects: including nausea, diarrhea, loss of appetite, fatigue, stomatitis, etc. If symptoms of discomfort persist, you should consult your doctor whether to adjust the dose or discontinue the drug.

In short, Apelvis is a targeted drug for PIK3CA mutated breast cancer. Patients must strictly follow the doctor's instructions when taking it and pay attention to blood sugar management and side effect monitoring to improve the treatment effect and reduce the risk of adverse reactions.

Reference materials:https://www.piqray.com/